Development of an adapted Clinical Global Impression scale for use in Angelman syndrome
ConclusionsRigorous training and careful calibration for clinicians will allow the CGI-S/-I-AS scales to be reliable in the context of randomized controlled trials. The CGI-S/-I-AS scales are being utilized in a Phase 3 trial of gaboxadol for the treatment of AS.
Source: Journal of Neurodevelopmental Disorders - Category: Neurology Source Type: research
More News: Angelman Syndrome | Brain | Clinical Trials | Neurology | Sleep Disorders | Sleep Medicine | Training | Universities & Medical Training